Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism RIPK3 modulators(receptor interacting serine/threonine kinase 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colonic Cancer | Preclinical | Egypt | 29 Sep 2025 | |
| Non-Small Cell Lung Cancer | Preclinical | Egypt | 29 Sep 2025 | |
| Osteosarcoma | Preclinical | Egypt | 29 Sep 2025 |





